| Shivanna V Kumar, MD | |
|
1111 E Spruce St, Garden City, KS 67846-5958 | |
| (620) 276-7689 | |
| (620) 276-6117 |
| Full Name | Shivanna V Kumar |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 48 Years |
| Location | 1111 E Spruce St, Garden City, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326147992 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 0420846 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Catherine Hospital | Garden city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Compass Behavioral Health | 1355323122 | 14 |
News Archive
Think about traffic flow in a city - there are stop signs, one-way streets, and traffic lights to organize movement across a widespread network. Now, imagine what would happen if you removed some of the traffic signals.
A consortium led by the Spanish National Cancer Research Centre's researcher Mar-a S. Soengas −Programme Director of the Centre-s Molecular Pathology Programme and Leader of the CNIO Melanoma Group− has been selected to receive funding from the Melanoma Research Alliance, the most important private international melanoma research foundation, in order to advance research in melanoma; this type of skin tumour represents one of oncology's biggest challenges due to its high incidence and malignancy.
Kaiser Health News provides a fresh perspective on health policy developments with "A Nation Divided" by John Rose.
The Associated Press examines the complicated issue of health costs by looking at foot amputations from diabetes.
St. Jude Medical, Inc., a global medical device company, today announced the first enrollments in the company's LEADLESS Pacemaker Observational Study evaluating the Nanostim leadless pacing technology. The Nanostim pacemaker received CE Mark in 2013, and post-approval implants have occurred in the UK, Germany, Italy, Czech Republic, France, Spain, and the Netherlands.
› Verified 1 days ago
| Entity Name | Compass Behavioral Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922058510 PECOS PAC ID: 1355323122 Enrollment ID: O20040604000376 |
News Archive
Think about traffic flow in a city - there are stop signs, one-way streets, and traffic lights to organize movement across a widespread network. Now, imagine what would happen if you removed some of the traffic signals.
A consortium led by the Spanish National Cancer Research Centre's researcher Mar-a S. Soengas −Programme Director of the Centre-s Molecular Pathology Programme and Leader of the CNIO Melanoma Group− has been selected to receive funding from the Melanoma Research Alliance, the most important private international melanoma research foundation, in order to advance research in melanoma; this type of skin tumour represents one of oncology's biggest challenges due to its high incidence and malignancy.
Kaiser Health News provides a fresh perspective on health policy developments with "A Nation Divided" by John Rose.
The Associated Press examines the complicated issue of health costs by looking at foot amputations from diabetes.
St. Jude Medical, Inc., a global medical device company, today announced the first enrollments in the company's LEADLESS Pacemaker Observational Study evaluating the Nanostim leadless pacing technology. The Nanostim pacemaker received CE Mark in 2013, and post-approval implants have occurred in the UK, Germany, Italy, Czech Republic, France, Spain, and the Netherlands.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shivanna V Kumar, MD 1111 E Spruce St, Garden City, KS 67846-5958 Ph: (620) 276-7689 | Shivanna V Kumar, MD 1111 E Spruce St, Garden City, KS 67846-5958 Ph: (620) 276-7689 |
News Archive
Think about traffic flow in a city - there are stop signs, one-way streets, and traffic lights to organize movement across a widespread network. Now, imagine what would happen if you removed some of the traffic signals.
A consortium led by the Spanish National Cancer Research Centre's researcher Mar-a S. Soengas −Programme Director of the Centre-s Molecular Pathology Programme and Leader of the CNIO Melanoma Group− has been selected to receive funding from the Melanoma Research Alliance, the most important private international melanoma research foundation, in order to advance research in melanoma; this type of skin tumour represents one of oncology's biggest challenges due to its high incidence and malignancy.
Kaiser Health News provides a fresh perspective on health policy developments with "A Nation Divided" by John Rose.
The Associated Press examines the complicated issue of health costs by looking at foot amputations from diabetes.
St. Jude Medical, Inc., a global medical device company, today announced the first enrollments in the company's LEADLESS Pacemaker Observational Study evaluating the Nanostim leadless pacing technology. The Nanostim pacemaker received CE Mark in 2013, and post-approval implants have occurred in the UK, Germany, Italy, Czech Republic, France, Spain, and the Netherlands.
› Verified 1 days ago